MATINAS BIOPHARMA HOLDINGS, INC.

(MTNB)
  Report
Delayed Nyse  -  05/19 04:00:00 pm EDT
0.6651 USD   +2.24%
05/12TRANSCRIPT : Matinas BioPharma Holdings, Inc., Q1 2022 Earnings Call, May 12, 2022
CI
05/12MATINAS BIOPHARMA HOLDINGS, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
05/12Matinas BioPharma Reports First Quarter 2022 Financial Results and Operational Highlights
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on MATINAS BIOPHARMA HOLDINGS, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) MATINAS BIOPHARMA HOLDINGS, INC.
Analyst Recommendations on MATINAS BIOPHARMA HOLDINGS, INC.
2021MATINAS BIOPHARMA : Piper Sandler Cuts Matinas BioPharma Holdings to Neutral From Overweight, Price Target to ..
MT
2021MATINAS BIOPHARMA : HC Wainwright Adjusts Price Target on Matinas BioPharma Holdings to $3 From $4, Maintains ..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 0,65 $
Average target price 2,75 $
Spread / Average Target 323%
High Price Target 3,00 $
Spread / Highest target 361%
Low Price Target 2,00 $
Spread / Lowest Target 207%
Consensus detail
Consensus revision (last 18 months)